Sencilia

Groningen, Netherlands · Founded 2021 · Privately Held (backing)

Developer of intravenous line infusion monitoring services intended to improve patient safety in neonatal and pediatric intensive care. Sencilia is based in Groningen, Netherlands and was founded in 2021. It has raised $860,000.

Last price · $/share
—
Implied valuation
—
Total raised
$860K
Last round
—
Valuation — not yet established

No valuation for Sencilia is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($860K) and the funding record below are the closest available signals.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Sencilia with a free account
  • ·The complete investor list: 14 names
  • ·Watch Sencilia: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Sencilia funding history

No rounds on record

No funding rounds for Sencilia are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

How Sencilia's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Sencilia, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked about Sencilia

How much has Sencilia raised?
Sencilia has raised $860K in total funding across its recorded rounds.